Home › Funds › Invenomic Capital Management LP › NICE

Invenomic Capital Management LP position in NICE

NICE LTD · Technology

Invenomic Capital Management LP reported holding 233,366 shares of NICE (NICE LTD) in its Q3 2026 13F filing — a position valued at US$26.0M, representing 1.28% of its reported portfolio and ranking #30 among its reported holdings. Invenomic Capital Management LP first reported this position in Q3 2026.

Latest position (Q3 2026)233.37K sh
Reported value held$25.97M
Portfolio Weight1.28%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Invenomic Capital Management LP's NICE position evolved

Invenomic Capital Management LP first disclosed a stake in NICE in Q3 2026 at 233,366 shares (US$26.0M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 233.37K $25.97M New

About NICE and 13F data

NICE (NICE LTD) is a Technology company. 11 other funds we track also report a position in NICE — the largest reported positions include BRANDES INVESTMENT PARTNERS, LP (US$323.7M), HARDING LOEVNER LP (US$217.1M), Clal Insurance Enterprises Holdings Ltd (US$173.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NICE

All NICE fund holders →

FAQ

How long has Invenomic Capital Management LP held NICE?

Invenomic Capital Management LP has disclosed NICE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Invenomic Capital Management LP's current position in NICE?

As of Q3 2026, Invenomic Capital Management LP holds 233.37K shares of NICE (NICE LTD), valued at $25.97M, representing 1.28% of its reported portfolio and ranking #30.

Has Invenomic Capital Management LP been buying or selling NICE?

In the latest 13F filing (Q3 2026), Invenomic Capital Management LP newly opened its position in NICE.

Which other funds hold NICE?

Other major institutional holders of NICE include BRANDES INVESTMENT PARTNERS, LP, HARDING LOEVNER LP, Clal Insurance Enterprises Holdings Ltd, among 11 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.